4,6-Dichloro-2-Methylpyrimidine CAS 1780-26-3 Puritas ≥99.5% (GC) Factory Hot Sale

Description:

Nomen chemicum: 4,6-Dichloro-2-Methylpyrimidine

CAS: 1780-26-3

Puritas: ≥99.5% (GC)

Aspectus: Alba vel Off-White Crystalline pulveris

High Quality, Commercial Production

Medium Dasatinib / Moxonidine

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of 4,6-Dichloro-2-Methylpyrimidine (CAS: 1780-26-3) with high quality, commercial production. We can provide COA, worldwide delivery, small and bulk quantities available. Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum 4,6-Dichloro-2-Methylpyrimidine
Synonyma 2-Methyl-4,6-Dichloropyrimidines;2,4-Dichloro-6-Methylpyrimidine
CAS Number 1780-26-3
CATTUS Number RF-PI687
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C5H4Cl2N2
M. Pondus 163.00
Liquescens punctum 41.5~45.5' (lit.)
Solubilitas (Solubile in) Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White Crystalline pulveris
Puritas / Analysis Methodus ≥99.5% (GC)
Damnum in Siccatio ≤0.50%
Residere in Ignition ≤0.20%
una immunditia ≤0.50%
Totalis immunditias ≤0.50%
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical Medium;Dasatinib/Moxonidine Intermediate

4,6-Dichloro-2-Methylpyrimidines (CAS: 1780-26-3) Processus Route

www.ruifuchemical.com

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

1

FAQ:

Applicatio:

4,6-Dichloro-2-Methylpyrimidines (CAS: 1780-26-3) adhibetur in synthesi intermediorum pharmaceuticorum et APIs.Praeparatio Products: Moxonidine (CAS: 75438-57-2);Dasatinib (CAS: 302962-49-8);Dasatinib Monohydratorum (CAS: 863127-77-9);4-Chloro-2,6-Dimethylpyrimidine (CAS: 4472-45-1);4-Amino-6-Chloro-2-Methylpyrimidine (CAS: 1749-68-4).Moxonidine est novum genus medicamentorum antihypertensivum, communiter in curatione hypertensionis essentialis.Comparatus cum antihypertensivis antihypertensivis centrali vetustioribus, Moxonidine ligat multo maiore affinitate cum imidazolino I1-receptori quam cum α2-receptatore.Dasatinib est inhibitor kinasus oncogenicus oralis potens, qui signum replicationis accelerationis cellae cancri obstruere potest, mense Maio 2009, US Cibus et Administration medicamentis (FDA) venditionem dasatinib formaliter approbavit , amet adhibitum est ad tractationem diversorum chronicorum. myeloid leukemia (CML), inter curationem myeloidalis longi leukemia quae resistit vel intolerans programmata tractandi possidet mesylata imatinib., Philadelphia chromosoma-positiva acuta leukemia lymphoblastica (Ph + ALL) et curatio aegrorum cum solidis tumoribus.

Epistulam tuam hic scribe et mitte nobis